Lantheus Holdings Reports Officer and Director Changes
Ticker: LNTH · Form: 8-K · Filed: Aug 11, 2025 · CIK: 1521036
| Field | Detail |
|---|---|
| Company | Lantheus Holdings, Inc. (LNTH) |
| Form Type | 8-K |
| Filed Date | Aug 11, 2025 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: officer-changes, director-changes, compensation
Related Tickers: LNTH
TL;DR
Lantheus Holdings (LNTH) filed an 8-K for officer/director changes and compensation effective Aug 7.
AI Summary
Lantheus Holdings, Inc. filed an 8-K on August 11, 2025, reporting changes effective August 7, 2025. The filing pertains to the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. Specific details regarding the individuals involved, their roles, and the nature of the compensatory arrangements are not provided in this excerpt.
Why It Matters
Changes in key leadership and officer compensation can signal shifts in company strategy or governance, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in executive and director positions, along with compensation adjustments, can introduce uncertainty about future company direction and stability.
Key Players & Entities
- Lantheus Holdings, Inc. (company) — Registrant
- August 7, 2025 (date) — Effective date of reported changes
- August 11, 2025 (date) — Filing date of the 8-K
FAQ
What specific changes were made regarding directors or officers?
The filing indicates the departure of directors or certain officers, the election of directors, and the appointment of certain officers, but the specific individuals and their roles are not detailed in this excerpt.
What is the effective date of the reported changes?
The earliest event reported is August 7, 2025.
When was this 8-K filing submitted to the SEC?
The filing was submitted on August 11, 2025.
Are there any details about the compensatory arrangements mentioned?
The filing notes that it pertains to compensatory arrangements of certain officers, but specific details are not provided in this excerpt.
What is Lantheus Holdings, Inc.'s primary business?
Lantheus Holdings, Inc. is involved in IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES, as indicated by its SIC code.
Filing Stats: 407 words · 2 min read · ~1 pages · Grade level 12.2 · Accepted 2025-08-11 17:02:48
Key Financial Figures
- $0.01 — ich registered Common stock, par value $0.01 per share LNTH The Nasdaq Global Ma
Filing Documents
- d88945d8k.htm (8-K) — 21KB
- 0001193125-25-178046.txt ( ) — 131KB
- lnth-20250807.xsd (EX-101.SCH) — 3KB
- lnth-20250807_lab.xml (EX-101.LAB) — 18KB
- lnth-20250807_pre.xml (EX-101.PRE) — 11KB
- d88945d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LANTHEUS HOLDINGS, INC. By: /s/ Daniel Niedzwiecki Name: Daniel Niedzwiecki Title: Chief Administrative Officer and General Counsel Date: August 11, 2025